Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study
Year: 2019
Type: article
Study design: Observational Study
Source: Allergy and Asthma Proceedings
Institution: Novartis (United States)
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2964586572
